The DOI matches its Crossref record; 102 of the 106 references it cites were found in a registry or an index; 7 of the 57 sources its claims cite were checked for support.
In Vivo versus Augmented Reality Exposure in the Treatment of Small Animal Phobia: A Randomized Controlled Trial
Open accessAbstract
Although in vivo exposure is the treatment of choice for specific phobias, some acceptability problems have been associated with it. Virtual Reality exposure has been shown to be as effective as in vivo exposure, and it is widely accepted for the treatment of specific phobias, but only preliminary data are available in the literature about the efficacy of Augmented Reality. The purpose of the present study was to examine the efficacy and acceptance of two treatment conditions for specific phobias in which the exposure component was applied in different ways: In vivo exposure (N = 31) versus an Augmented Reality system (N = 32) in a randomized controlled trial. "One-session treatment" guidelines were followed. Participants in the Augmented Reality condition significantly improved on all the outcome measures at post-treatment and follow-ups. When the two treatment conditions were compared, some differences were found at post-treatment, favoring the participants who received in vivo exposure. However, these differences disappeared at the 3- and 6-month follow-ups. Regarding participants' expectations and satisfaction with the treatment, very positive ratings were reported in both conditions. In addition, participants from in vivo exposure condition considered the treatment more useful for their problem whereas participants from Augmented Reality exposure considered the treatment less aversive. Results obtained in this study indicate that Augmented Reality exposure is an effective treatment for specific phobias and well accepted by the participants. © 2016 Botella et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Overview
CoChat Summary
## TL;DR
This randomized controlled trial compared one-session in vivo exposure with augmented reality exposure for small animal phobia (cockroaches/spiders) in 63 adults. Both treatments produced large, sustained improvements through 6 months; in vivo had some post-treatment advantages, but these differences did not persist.
## Key findings
- 63 participants were randomized: 31 to in vivo exposure (IVE) and 32 to augmented reality exposure (ARE); the sample was 93.7% women, and 85.7% had cockroach phobia.
- In the intention-to-treat analysis, there was a significant time effect on all BAT measures: Fear-BAT (F3, 61 = 58.73, p < .000), Avoidance-BAT (F3, 61 = 65.59, p < .000), Belief-BAT (F3, 61 = 86.71, p < .000), Performance-BAT (F3, 61 = 209.61, p < .000), maximum anxiety-BAT (F3, 61 = 45.49, p < .000), and clinician-rated Severity-BAT (F3, 60 = 89.14, p < .000).
- The only BAT variable with a significant between-group interaction in ITT was Avoidance-BAT (F3, 61 = 65.59, p < .020), favoring IVE at post-treatment; this difference was not present at 3- or 6-month follow-ups. In the completer analysis, a similar post-treatment advantage favored IVE on Fear-BAT (F3, 45 = 3.42, p < .029), again disappearing at follow-up.
- The paper reports that all measures reached Cohen’s d > 0.8 in both conditions at post-treatment and follow-ups; the authors also state that 22/31 (71.0%) in IVE and 18/32 (56.3%) in ARE were diagnosis-free at post-treatment, rising to 24/31 (77.4%) and 22/32 (68.8%) at 3 months, and 20/31 (64.5%) and 20/32 (62.5%) at 6 months.
## Methods
- Design: Randomized controlled trial with two conditions: in vivo exposure (IVE) and augmented reality exposure (ARE), following one-session treatment guidelines; assessments occurred at pre-treatment, post-treatment, 3 months, and 6 months.
- Sample/data: Adults 18+ with DSM-IV-TR specific phobia, animal subtype (cockroaches or spiders), recruited via university mailing lists, campus announcements, and local media; 63 participants were included after eligibility screening.
- Analysis: Between-group baseline comparisons used chi-square tests and t tests; treatment effects were analyzed with repeated-measures ANOVAs in both intention-to-treat (LOCF) and completer analyses; Cohen’s d was calculated, and chi-square tests assessed clinically significant improvement.
## Limitations
- The paper states there was no waiting list control group, because the authors chose to compare AR with the strongest current treatment, in vivo exposure.
- The authors state the sample size did not allow equivalence testing, so they could not conclude the two treatments were equally efficacious.
- The study was conducted in a research context, so the paper states that no data about clinical settings or clinicians’ acceptance were obtained; it also notes no diagnostic interrater reliability was applied because assessors were not always independent from therapists.
- Evident from the text: the sample was small and heavily female (93.7%), and outcomes were limited to adults with cockroach or spider phobia, which constrains generalization.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
5 Valid · 0 Not valid · 22 Not checked · 52 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“VR is also well accepted [24,36,37], even in children [38].”
§ In Vivo versus Augmented Reality Exposure in the Treatment of Small Animal Phobia: A Randomized Controlled Trial > Introduction
What the sources say
- Not checked — no full text of the sourcecites [24] A Garcia-Palacios, 2007, Comparing acceptance and refusal rates of virtual reality exposure vs. in vivo exposure by patients with specific phobias, Cyberpsychol Behav source
- Not checked — no full text of the sourcecites [36] S Quero, 2014, Acceptability of virtual reality interoceptive exposure for the treatment of panic disorder with agoraphobia, Br J Guid Counc source
- Not checked — no full text of the sourcecites [37] BO Rothbaum, 2006, Virtual reality exposure therapy and standard (in vivo) exposure therapy in the treatment of fear of flying, Behav Ther source
- Supportedcites [38] NW Sarver, 2014, The Feasibility and Acceptability of Virtual Environments in the Treatment of Childhood Social Anxiety Disorder, J Clin Child Adol Psychol source
The Results report that children were satisfied with the virtual-environment treatment, supporting the cited sentence’s “even in children” point. The study concerns childhood social anxiety disorder, not specific phobias. (LLM, conf=0.91)
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“These studies are in line with the work carried out by Craske et al. [81], focused on optimizing exposure therapy based on the inhibitory learning approach, because VR/AR can maximize some strategies reported by Craske.”
§ In Vivo versus Augmented Reality Exposure in the Treatment of Small Animal Phobia: A Randomized Controlled Trial > Discussion
What the sources say
- Supportedcites Craske et al. [81] MG Craske, 2014, Maximizing exposure therapy: An inhibitory learning approach, Behav Res Ther source
The sections on Deepened Extinction, Variability, and Multiple Contexts each describe the corresponding exposure strategy. The statement that VR/AR can maximize those strategies is the citing authors’ application of Craske et al.’s framework, not a finding attributed to Craske et al. (LLM, conf=0.90)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Regarding participants’ expectations and satisfaction with the treatment, very positive ratings were reported in both conditions.”
§ In Vivo versus Augmented Reality Exposure in the Treatment of Small Animal Phobia: A Randomized Controlled Trial > Abstract Although in vivo exposure is the treatment of choice for specific phobias, some acceptability problems have been associated with it. Virtual Reality exposure has been shown to be as effective as in vivo exposure, and it is widely accepted for the treatment of specific phobias, but only preliminary data are available in the literature about the efficacy of Augmented Reality. The purpose of the present study was to examine the efficacy and acceptance of two treatment conditions for specific phobias in which the exposure component was applied in different ways: In vivo exposure (N = 31) versus an Augmented Reality system (N = 32) in a randomized controlled trial. “One-session treatment” guidelines were followed. Participants in the Augmented Reality condition significantly improved on all the outcome measures at post-treatment and follow-ups. When the two treatment conditions were compared, some differences were found at post-treatment, favoring the participants who received in vivo exposure. However, these differences disappeared at the 3- and 6-month follow-ups. Regarding participants’ expectations and satisfaction with the treatment, very positive ratings were reported in both conditions. In addition, participants from in vivo exposure condition considered the treatment more useful for their problem whereas participants from Augmented Reality exposure considered the treatment less aversive. Results obtained in this study indicate that Augmented Reality exposure is an effective treatment for specific phobias and well accepted by the participants.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“participants from in vivo exposure condition considered the treatment more useful for their problem whereas participants from Augmented Reality exposure considered the treatment less aversive.”
§ In Vivo versus Augmented Reality Exposure in the Treatment of Small Animal Phobia: A Randomized Controlled Trial > Abstract Although in vivo exposure is the treatment of choice for specific phobias, some acceptability problems have been associated with it. Virtual Reality exposure has been shown to be as effective as in vivo exposure, and it is widely accepted for the treatment of specific phobias, but only preliminary data are available in the literature about the efficacy of Augmented Reality. The purpose of the present study was to examine the efficacy and acceptance of two treatment conditions for specific phobias in which the exposure component was applied in different ways: In vivo exposure (N = 31) versus an Augmented Reality system (N = 32) in a randomized controlled trial. “One-session treatment” guidelines were followed. Participants in the Augmented Reality condition significantly improved on all the outcome measures at post-treatment and follow-ups. When the two treatment conditions were compared, some differences were found at post-treatment, favoring the participants who received in vivo exposure. However, these differences disappeared at the 3- and 6-month follow-ups. Regarding participants’ expectations and satisfaction with the treatment, very positive ratings were reported in both conditions. In addition, participants from in vivo exposure condition considered the treatment more useful for their problem whereas participants from Augmented Reality exposure considered the treatment less aversive. Results obtained in this study indicate that Augmented Reality exposure is an effective treatment for specific phobias and well accepted by the participants.
plainn = 31- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Participants in the Augmented Reality condition significantly improved on all the outcome measures at post-treatment and follow-ups.”
§ In Vivo versus Augmented Reality Exposure in the Treatment of Small Animal Phobia: A Randomized Controlled Trial > Abstract Although in vivo exposure is the treatment of choice for specific phobias, some acceptability problems have been associated with it. Virtual Reality exposure has been shown to be as effective as in vivo exposure, and it is widely accepted for the treatment of specific phobias, but only preliminary data are available in the literature about the efficacy of Augmented Reality. The purpose of the present study was to examine the efficacy and acceptance of two treatment conditions for specific phobias in which the exposure component was applied in different ways: In vivo exposure (N = 31) versus an Augmented Reality system (N = 32) in a randomized controlled trial. “One-session treatment” guidelines were followed. Participants in the Augmented Reality condition significantly improved on all the outcome measures at post-treatment and follow-ups. When the two treatment conditions were compared, some differences were found at post-treatment, favoring the participants who received in vivo exposure. However, these differences disappeared at the 3- and 6-month follow-ups. Regarding participants’ expectations and satisfaction with the treatment, very positive ratings were reported in both conditions. In addition, participants from in vivo exposure condition considered the treatment more useful for their problem whereas participants from Augmented Reality exposure considered the treatment less aversive. Results obtained in this study indicate that Augmented Reality exposure is an effective treatment for specific phobias and well accepted by the participants.
plainstates a causen = 32- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
27 more claims
Create a free account to see all 79 claims and to verify the 3 references still open.
- Probably not a substantial claim. 28
- It may state two separate claims as one. 34
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“The minimum sample size for each group was identified as 26 (78 in total), but at least an additional 20% will be recruited to take into account expected follow-up attrition; thus, a minimum total sample of 96 participants (32 per group) is estimated.15 34”
From Effectiveness of a projection-based augmented reality exposure system in treating cockroach phobia: Study protocol of a randomised controlled trial (2023) · cites this paper as [15]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The appearance of new AR systems has made it possible to overcome some of the problems associated with this type of technology such as dizziness and discomfort caused by intensive use of a traditional HMD.15”
From Effectiveness of a projection-based augmented reality exposure system in treating cockroach phobia: Study protocol of a randomised controlled trial (2023) · cites this paper as [15]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Power calculations were performed using Epidat V.4.2 statistical software to estimate the sample size necessary to detect a large standardised mean difference between groups (Cohen’s d=0.80) with a power of 0.80 and an alpha of 0.05, based on previous studies using AR systems.15 21”
From Effectiveness of a projection-based augmented reality exposure system in treating cockroach phobia: Study protocol of a randomised controlled trial (2023) · cites this paper as [15]
The cited source says what the claim attributes to it.
In the citing paper
“In the aforementioned RCT, some patients in the ARET group reported dizziness and back pain due to the use of the HMD.15”
From Effectiveness of a projection-based augmented reality exposure system in treating cockroach phobia: Study protocol of a randomised controlled trial (2023) · cites this paper as [15]
The cited source says what the claim attributes to it.
In the citing paper
“This study revealed that participants in the ARET condition showed significant reductions in all the fear outcomes that were maintained at the follow-ups.15”
From Effectiveness of a projection-based augmented reality exposure system in treating cockroach phobia: Study protocol of a randomised controlled trial (2023) · cites this paper as [15]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
“A significant time X treatment group interaction effect was found for the variable “Avoidance-BAT” (F3, 61 = 65.59, p < .020), with this interaction favoring the participants in the IVE condition.”
§ In Vivo versus Augmented Reality Exposure in the Treatment of Small Animal Phobia: A Randomized Controlled Trial > Results > Effectiveness: change in primary and secondary outcomes at pre-post and 3- and 6-month follow-ups in both treatment conditions
Reported 0.02 · recomputed 65.57
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Statistical Power Analysis for the Behavioral Sciences
Muller, K. (1989) · Technometrics · doi:10.1080/00401706.1989.10488618 · Cited by 99,167
Statistical power analysis for the behavioral sciences
(1990) · Computers, Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,269
Statistical Power Analysis for the Behavioral Sciences (2nd ed.).
Lachenbruch, P. A., & Cohen, J. (1989) · Journal of the American Statistical Association · doi:10.2307/2290095 · Cited by 37,395
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052 · cited 1×
“7%) [1] among the USA population, whereas lower prevalence were found in some European countries (3.”
BackgroundAzuma, R. T. (1997) · Presence: Teleoperators and Virtual Environments · doi:10.1162/pres.1997.6.4.355 · Cited by 10,121
Moher, D., Hopewell, S., Schulz, K. F., Montori, V., Gotzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2010) · BMJ · doi:10.1136/bmj.c869 · Cited by 8,883 · cited 1×
“The RCT was conducted in accordance with the CONSORT 2010 Statement [51] and the CONSORT-EHEALTH guidelines [52,53] to study the efficacy of two experimental conditions: 1) In Vivo Exposure and 2) Augmented Reality Exposure (see S1 CONSORT Checklist).”
MethodDiagnostic and Statistical Manual of Mental Disorders
Siegel, L. J., & Fletcher‐Janzem, E. (2008) · Encyclopedia of Special Education · doi:10.1002/9780470373699.speced0655 · Cited by 8,477
Jacobson, N. S., & Truax, P. (1991) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.59.1.12 · Cited by 7,770 · cited 2×
“Finally, Chi-squared tests were performed in order to examine the differential clinically significant improvement rates, based on the Jacobson and Truax indexes [70] for FSQ and SBQ scores at post-treatment and 3- and 6-month follow-ups in the two treatment conditions.”
MethodMoher, D., Schulz, K. F., & Altman, D. G. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04337-3 · Cited by 5,373
Research works printed but not linked: 3
- S Quero, 2014, ICERI2014: Proceedings of the 7th International Technology, Education, and Development Conference; 2014 nov 17–19, 1568
- Nebot S, Quero S, Bretón-López J, Pérez-Ara MA, Botella C. Validación Española del Cuestionario de Miedo a las Arañas (FSQ) adaptado para la Fobia a las Cucarachas. SEAS2012: Poster presentation at the IX International Conference of the Sociedad Española para el estudio de la Ansiedad y Estrés; 2012 Sep 6–8; Valencia, Spain.
- S Corbett-Davies, 2012, Proceeding of the 11th IEEE International Symposium on Mixed and Augmented Reality (ISMAR)
Cited by
Recent Progress in Virtual Reality Exposure Therapy for Phobias: A Systematic Review
Botella, C., Fernández-Álvarez, J., Guillén, V., García-Palacios, A., & Baños, R. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0788-4 · Cited by 460
Self-citationMiloff, A., Lindner, P., Dafgård, P., Deak, S., Garke, M., Hamilton, W., Heinsoo, J., Kristoffersson, G., Rafi, J., Sindemark, K., et al. (2019) · Behaviour Research and Therapy · doi:10.1016/j.brat.2019.04.004 · Cited by 155
Review of virtual reality treatment in psychiatry: evidence versus current diffusion and use
Mishkind, M. C., Norr, A. M., Katz, A. C., & Reger, G. M. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0836-0 · Cited by 136
Virtual Reality for the Enhancement of Emotion Regulation
Colombo, D., Díaz‐García, A., Fernandez‐Álvarez, J., & Botella, C. (2021) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.2618 · Cited by 120
Self-citationMaffei, L., Masullo, M., Pascale, A., Ruggiero, G., & Puyana‐Romero, V. (2016) · Sustainable Cities and Society · doi:10.1016/j.scs.2016.06.022 · Cited by 130
Metadata
- Authors
- Botella, C., Pérez-Ara, M. Á., Bretón-López, J., Quero, S., García-Palacios, A., & Baños, R. M.
- Affiliations
- Universitat Jaume I (ES)
- Universitat de València (ES)
- Corresponding author
- Botella, Cristina
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-02-17
- Volume
- 11
- Issue
- 2
- Pages
- e0148237
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4757089
- OpenAlex
- W2274466416
- Cited by
- 124
- References
- 106
- Citations by year
- 2026: 9 · 2025: 12 · 2024: 8 · 2023: 17 · 2022: 16 · 2021: 21 · 2020: 13 · 2019: 13 · 2018: 7 · 2017: 6 · 2016: 2
- FWCI
- 13.25
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
- Repositori UJI (Universitat Jaume I) (submittedVersion, cc-by-sa)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Ministerio de Economía y Competitividad
- Instituto de Salud Carlos III
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Physical Sciences › Computer Science › Human-Computer Interaction › Virtual Reality Applications and Impacts
- Physical Sciences › Computer Science › Computer Vision and Pattern Recognition › Augmented Reality Applications
- Keywords
- in vivo exposure, specific phobia, virtual reality exposure, exposure therapy, treatment acceptability, treatment satisfaction, single-session intervention, treatment efficacy
- MeSH terms
- Adult, Aged, Animals, Cockroaches, Female, Follow-Up Studies, Humans, Male, Middle Aged, Phobic Disorders, Spiders, Treatment Outcome, Young Adult, Intention to Treat Analysis, Virtual Reality Exposure Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: In Vivo versus Augmented Reality Exposure in the Treatment of Small Animal Phobia: A Randomized Controlled Trial. https://app.cochat.ai/papers/10.1371/journal.pone.0148237
- The paper
- Botella, C., Pérez-Ara, M. Á., Bretón-López, J., Quero, S., García-Palacios, A., & Baños, R. M. (2016). In Vivo versus Augmented Reality Exposure in the Treatment of Small Animal Phobia: A Randomized Controlled Trial. PLoS ONE. https://doi.org/10.1371/journal.pone.0148237
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.